BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31539251)

  • 1. Exploiting Cryo-EM Structural Information and All-Atom Simulations To Decrypt the Molecular Mechanism of Splicing Modulators.
    Borišek J; Saltalamacchia A; Spinello A; Magistrato A
    J Chem Inf Model; 2020 May; 60(5):2510-2521. PubMed ID: 31539251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cryo-EM structure of the SF3b spliceosome complex bound to a splicing modulator reveals a pre-mRNA substrate competitive mechanism of action.
    Finci LI; Zhang X; Huang X; Zhou Q; Tsai J; Teng T; Agrawal A; Chan B; Irwin S; Karr C; Cook A; Zhu P; Reynolds D; Smith PG; Fekkes P; Buonamici S; Larsen NA
    Genes Dev; 2018 Feb; 32(3-4):309-320. PubMed ID: 29491137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex.
    Teng T; Tsai JH; Puyang X; Seiler M; Peng S; Prajapati S; Aird D; Buonamici S; Caleb B; Chan B; Corson L; Feala J; Fekkes P; Gerard B; Karr C; Korpal M; Liu X; T Lowe J; Mizui Y; Palacino J; Park E; Smith PG; Subramanian V; Wu ZJ; Zou J; Yu L; Chicas A; Warmuth M; Larsen N; Zhu P
    Nat Commun; 2017 May; 8():15522. PubMed ID: 28541300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the Molecular Mechanism of H3B-8800: A Splicing Modulator Inducing Preferential Lethality in Spliceosome-Mutant Cancers.
    Spinello A; Borišek J; Malcovati L; Magistrato A
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disclosing the Impact of Carcinogenic SF3b Mutations on Pre-mRNA Recognition Via All-Atom Simulations.
    Borišek J; Saltalamacchia A; Gallì A; Palermo G; Molteni E; Malcovati L; Magistrato A
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31640290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SF3B1/Hsh155 HEAT motif mutations affect interaction with the spliceosomal ATPase Prp5, resulting in altered branch site selectivity in pre-mRNA splicing.
    Tang Q; Rodriguez-Santiago S; Wang J; Pu J; Yuste A; Gupta V; Moldón A; Xu YZ; Query CC
    Genes Dev; 2016 Dec; 30(24):2710-2723. PubMed ID: 28087715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds.
    Cretu C; Agrawal AA; Cook A; Will CL; Fekkes P; Smith PG; Lührmann R; Larsen N; Buonamici S; Pena V
    Mol Cell; 2018 Apr; 70(2):265-273.e8. PubMed ID: 29656923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface.
    Loerch S; Leach JR; Horner SW; Maji D; Jenkins JL; Pulvino MJ; Kielkopf CL
    J Biol Chem; 2019 Feb; 294(8):2892-2902. PubMed ID: 30567737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlapping roles of spliceosomal components SF3B1 and PHF5A in rice splicing regulation.
    Butt H; Bazin J; Alshareef S; Eid A; Benhamed M; Reddy ASN; Crespi M; Mahfouz MM
    Commun Biol; 2021 May; 4(1):529. PubMed ID: 33953336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U2AF65-Dependent SF3B1 Function in SMN Alternative Splicing.
    Choi N; Liu Y; Oh J; Ha J; Zheng X; Shen H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33317029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and mechanistic insights into human splicing factor SF3b complex derived using an integrated approach guided by the cryo-EM density maps.
    Rakesh R; Joseph AP; Bhaskara RM; Srinivasan N
    RNA Biol; 2016 Oct; 13(10):1025-1040. PubMed ID: 27618338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma.
    Sciarrillo R; Wojtuszkiewicz A; El Hassouni B; Funel N; Gandellini P; Lagerweij T; Buonamici S; Blijlevens M; Zeeuw van der Laan EA; Zaffaroni N; Deraco M; Kusamura S; Würdinger T; Peters GJ; Molthoff CFM; Jansen G; Kaspers GJL; Cloos J; Giovannetti E
    EBioMedicine; 2019 Jan; 39():215-225. PubMed ID: 30581150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages.
    Effenberger KA; Urabe VK; Prichard BE; Ghosh AK; Jurica MS
    RNA; 2016 Mar; 22(3):350-9. PubMed ID: 26742993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Related Mutations Alter RNA-Driven Functional Cross-Talk Underlying Premature-Messenger RNA Recognition by Splicing Factor SF3b.
    Spinello A; Janos P; Rozza R; Magistrato A
    J Phys Chem Lett; 2023 Jul; 14(27):6263-6269. PubMed ID: 37399065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Architecture of SF3b and Structural Consequences of Its Cancer-Related Mutations.
    Cretu C; Schmitzová J; Ponce-Salvatierra A; Dybkov O; De Laurentiis EI; Sharma K; Will CL; Urlaub H; Lührmann R; Pena V
    Mol Cell; 2016 Oct; 64(2):307-319. PubMed ID: 27720643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A UHM-ULM interface with unusual structural features contributes to U2AF2 and SF3B1 association for pre-mRNA splicing.
    Galardi JW; Bela VN; Jeffery N; He X; Glasser E; Loerch S; Jenkins JL; Pulvino MJ; Boutz PL; Kielkopf CL
    J Biol Chem; 2022 Aug; 298(8):102224. PubMed ID: 35780835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Overview of Structure-Activity Relationships of Small-Molecule Splicing Modulators Targeting SF3B1 as Anticancer Agents.
    Zhang D; Meng F
    ChemMedChem; 2020 Nov; 15(22):2098-2120. PubMed ID: 33037739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of SF3b1 reveal a dynamic Achilles heel of spliceosome assembly: Implications for cancer-associated abnormalities and drug discovery.
    Maji D; Grossfield A; Kielkopf CL
    Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194440. PubMed ID: 31707043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
    Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
    Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase 1 (CDK1) and CDK2 have opposing roles in regulating interactions of splicing factor 3B1 with chromatin.
    Murthy T; Bluemn T; Gupta AK; Reimer M; Rao S; Pillai MM; Minella AC
    J Biol Chem; 2018 Jun; 293(26):10220-10234. PubMed ID: 29764937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.